Expert Care for Women 35-65
Midi Health is a virtual clinic that offers specialized, insurance-covered menopause and perimenopause care.
We're a healthcare provider—not a vendor. And we may already be in-network with your organization's health plan.
If so, you can start offering Midi to employees nationwide and have services billed directly to claims today.
Real Care, Real Impact on Your Workforce
Hormonal decline can quietly erode focus, drain energy, sap motivation, and touch nearly every corner of a woman’s life—including her job.
The value of lost work days and health care related to insufficient menopause symptom management alone: $24.8 billion.
Midi moves the needle in ways that matter to women and your business.
Helping Women Thrive
While the average age of menopause is about 52, perimenopause (when hormonal decline begins) can start as early as a woman's 30s.
Midi cares for women throughout their menopause journey, supporting your multi-generational workforce.
Expand each care tile to learn more about Midi's programs.
Menopause & Perimenopause
Weight Management
Chronic Disease Risk Management
Trusted, Convenient, Effective
Our expert staff clinicians meet with patients via telehealth visits and create science-informed, personalized Care Plans to holistically address their concerns.
And because we offer virtual visits 7 days a week, daytime and evening hours, women can easily get the help they need.
With that comes:
* Faster relief
* Proactive prevention
* More coordinated care
* Less time off work for doctors' appointments
* Reduced healthcare utilization
The Experience
View highlights of the patient journey, from registration to virtual visit to treatment.
Watch VideoThe Outcomes
Read The Unstoppable Workforce report, which includes survey results on work life before and after Midi care.
Get the ReportMidi reaches women where they are
Instagram, TikTok, Reddit, podcasts, TV, and more
Are You Ready?
Click the button below to check if your organization's health plan recognizes Midi as an in-network provider and learn how easy it is to connect women with care that can make a difference.
- 2024 survey of Midi patients.
- Internal Midi study of 4,816 patients who had a weight visit as their first Midi visit.
- Based on ~3,600 Midi patients with 3+ visits since January 2023 who also had 2+ lab values 60+ days apart.
- Screening rates reflect a cohort of ~70,000 Midi patients with 3+ visits since January 2023 who met HEDIS criteria for colorectal and breast cancer screenings. Patients with a history of mastectomy (n ≈ 400) were excluded.
- Based on retrospective study of 2024 Blue Shield CA claims data that matched Midi patients with comparison group.